Afleveringen
-
This 3-part series aims to provide valuable insights and guidance to nurses interested in research. Hosted by moderator Sarah D. Williams from The American Heart Association, this series will leverage the expertise of experienced nurse researchers to inspire and educate nurses on engaging with research and scholarly inquiry.
-
This 3-part series aims to provide valuable insights and guidance to nurses interested in research. Hosted by moderator Sarah D. Williams from The American Heart Association, this series will leverage the expertise of experienced nurse researchers to inspire and educate nurses on engaging with research and scholarly inquiry.
-
Zijn er afleveringen die ontbreken?
-
This 3-part series aims to provide valuable insights and guidance to nurses interested in research. Hosted by moderator Sarah D. Williams from The American Heart Association, this series will leverage the expertise of experienced nurse researchers to inspire and educate nurses on engaging with research and scholarly inquiry.
-
This podcast provides an in-depth exploration of Lipoprotein(a) [Lp(a)] as an under-recognized, risk enhancing factor for cardiovascular disease, with particular emphasis on its impact on women’s cardiovascular health. This discussion features two Lp(a) experts, Dr. Saucier, a non-invasive cardiologist and Director of the Women's Heart Wellness Program and Dr. Fernandez, a cardiologist, and a lipidologist both from the Hartford Health Care System. These clinicians share their insights on Lp(a) and its considerations for women, screening approaches and treatment, clinical recommendations, and awareness.
-
This two-part podcast series investigates the clinical significance of lipoprotein(a) in cardiovascular and cerebrovascular health. The discussion features two expert doctors, Dr. Shah, a preventive cardiologist, and Dr. El Husseini, a vascular neurologist, both from Duke University Health System. These experts share their insights on the implications of elevated Lp(a) levels in patients and how it could shape future medical practices in addition to covering background on Lp(a), some of the evolving testing practices and clinical actionability.
-
This two-part podcast series investigates the clinical significance of lipoprotein(a) in cardiovascular and cerebrovascular health. The discussion features two expert doctors, Dr. Shah, a preventive cardiologist, and Dr. El Husseini, a vascular neurologist, both from Duke University Health System. These experts share their insights on the implications of elevated Lp(a) levels in patients and how it could shape future medical practices in addition to covering background on Lp(a), some of the evolving testing practices and clinical actionability.
-
This week's episode will delve into the complex workflows within a health system and how they be a help or a hinderance to an AFib patient once they are discharge. Our guest will demonstrate effective strategies that allow collaboration both within the hospital as well as with external clinics to ensure that care management does not end at discharge.
-
This week's episode provides a roadmap for creating a culture of high-quality Afib care within a health system. We'll discuss the importance of anticoagulant therapy and Afib management education outside of the electrophysiology and cardiology teams, how this education is reflected in other care settings, and how this can be replicated.
-
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.
-
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.
-
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.
-
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.
-
This episode explores the medications involved in treating hyperlipidemia-related ASCVD from a pharmacist perspective and the common patient misconceptions surrounding these interventions.
Speaker:
Megan Supple, PharmD, BCACP, CPP
Ambulatory Care Pharmacist
Cone Health Medical Group Cardiovascular Division
-
This episode examines the most common patient perceived barriers to treatment and management strategies to overcome these situations in the outpatient/clinic setting.
Speaker:
Kevin Hwang, MD
Associate Professor of Internal Medicine at McGovern Medical School
Medical Director, UT General Internal Medicine clinic in the Texas Medical Center
-
This episode evaluates pathways to identify adults with high ASCVD risk and intervention with lipid-lowering therapy in the Emergency Department.
Speaker:
James Langabeer, MD
Professor of Emergency Medicine
Vice Chair- Population Health
-
This episode lays the groundwork for our understanding of ASCVD lipid management. Our guest will walk through the algorithm for treatment to guidelines as well as address the barriers, pitfalls, and potential solutions in managing care.
Speaker:
Dr. Murtuza Ali ,MD
Professor of Clinical Medicine
Program Director- Interventional Cardiology Fellowship
Louisiana State University School of Medicine
-
Julia Zumpano, a Registered Dietician meets with Kattia to discuss her ASCVD and the effects that her diet and exercise can improve and further prevent future events.
- Laat meer zien
